Kleanthis G. Xanthopoulos, Ph. D.
President & Chief Executive Officer
"The Impact of microRNA Medicines"
Neil W. Gibson, Ph. D.
Chief Scientific Officer
"microRNAs as a New Class of Drug Targets"
Senior Vice President of Human Capital
"Culture and Core Values"